S-105 21 Stockholm, Sweden; manufacturing facilities in Matfors, Sweden; originally the Swedish Institute for Infectious Disease Control; privatized and became SBVaccin AB in 1993; acquired byActive Biotech AB in 1997; acquired by PowderJect in 2001, with PowderJect subsequently acquired by Chiron Corp.; company underwent a management buy-out, completed in May 2004; acquired in Nov. 2006 by Crucell N.V., which was acquired by Johnson & Johnson; Besides Dukoral (cholera and traveller’s diarrhea vaccine), SBL also manufactures inactivated poliovirus vaccine (IPV) used in Sweden.
